rare cause of recurrent haemolytic anaemia: carboplatin and paclitaxel-induced autoimmune haemolytic anaemia
Drug-induced immune haemolytic anaemia (DIIHA) is a rare but serious complication affecting approximately 1 in 1,000,000 patients, but its incidence might be underestimated due to misdiagnosis. Several factors should be considered to ensure an accurate diagnosis, including previous medical history,...
Main Authors: | Pitchaporn Yingchoncharoen, Jerapas Thongpiya, Shrinkhala Maharjan, Mahmoud Abdelnabi, Samuel Kim, Sakditad Saowapa, Judy Lalmuanpuii |
---|---|
Format: | Article |
Language: | English |
Published: |
SMC MEDIA SRL
2023-02-01
|
Series: | European Journal of Case Reports in Internal Medicine |
Subjects: | |
Online Access: | https://ejcrim.com/index.php/EJCRIM/article/view/3740 |
Similar Items
-
New insights in diagnostics and treatment of autoimmune haemolytic anaemia
by: Mirela Raos, et al.
Published: (2023-03-01) -
Carboplatin plus Paclitaxel in the First Line Therapy of Recurrent and Advances Endometrial Cancer
by: Hamid Attarian, et al.
Published: (2009-07-01) -
Carboplatin plus Paclitaxel in the First Line Therapy of Recurrent and Advances Endometrial Cancer
by: Hamid Attarian, et al.
Published: (2009-09-01) -
Ischemic Colitis Associated with Paclitaxel and Carboplatin Combination
by: Ahmed Gamal Elsayed, et al.
Published: (2017-08-01) -
Acute peripheral pulmonary embolism attributed to autoimmune haemolytic anaemia: a case report
by: Jing Xu, et al.
Published: (2020-03-01)